Skip to main content
SD BIOSENSOR INC. logo

SD BIOSENSOR INC. — Investor Relations & Filings

Ticker · 137310 ISIN · KR7137310009 KO Manufacturing
Open in API
Filings indexed 337 across all filing types
Latest filing 2023-07-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 137310

About SD BIOSENSOR INC.

https://www.sdbiosensor.com/

SD BIOSENSOR INC. is an in-vitro diagnostics company that develops, manufactures, and supplies point-of-care (POC) diagnostic solutions. The company specializes in rapid diagnostic tests (RDTs), biosensors, and diagnostic reagents aimed at the early and accurate diagnosis, prevention, and management of diseases. A key product is the STANDARD M, a point-of-care molecular diagnostics (MDx) system designed for fast and simple clinical decision-making near the patient. Through its focus on innovative biosensor technology, the company aims to improve the quality of life by providing accessible and reliable diagnostic tools.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권) (2023.07)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Supervisory Service (DART) in South Korea. It contains detailed information regarding the company's business, financial risks, and investment factors, specifically focusing on a correction (정정신고) to a previously filed registration statement. This type of document is a formal regulatory filing required for public offerings or capital changes, which falls under the 'Regulatory Filings' category as it is a comprehensive legal disclosure document.
2023-07-04 Korean
[기재정정]증권신고서(지분증권) (2023.07)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by SD Biosensor. It details specific corrections to sections of a previously filed securities registration statement, including business risks, financial data, and legal/regulatory disclosures. In the context of financial filings, a Securities Registration Statement (and its amendments) is a regulatory filing required for public offerings or capital changes. Since it does not fit into specific categories like '10-K' (Annual Report) or 'SHA' (Share Issue announcement), and is a formal regulatory submission to the financial authorities, it is classified as a Regulatory Filing (RNS).
2023-06-27 Korean
[기재정정]증권신고서(지분증권) (2023.07)
Capital/Financing Update Classification · 1% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details a capital increase (유상증자) by SD Biosensor, including information on the offering, investment risks, and financial status. This type of regulatory filing for capital raising is classified as a 'Capital/Financing Update' (CAP) within the provided schema.
2023-06-27 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean Financial Supervisory Service (FSS) regarding a decision to issue new shares (유상증자결정). It details the number of shares, pricing, purpose of funds, and subscription methods. This falls under the category of capital structure changes and share issuance announcements.
2023-06-13 Korean
타법인주식및출자증권취득결정
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from SD Biosensor regarding the 'Decision to Acquire Shares and Securities of Another Corporation' (타법인주식및출자증권취득결정). This is a standard corporate disclosure in the Korean market (DART/KIND system) detailing an investment in a subsidiary (Columbus Holding Company). While it involves capital, it is specifically a disclosure of an investment/acquisition decision rather than a general financing update or M&A takeover bid. Given the specific nature of the disclosure regarding the acquisition of shares in another entity, it falls under the category of Regulatory Filings (RNS) as it is a mandatory disclosure of a corporate event.
2023-06-13 Korean
유상증자결정(종속회사의주요경영사항)(Columbus Holding Company)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from SD Biosensor regarding a capital increase (paid-in capital increase) by its subsidiary, Columbus Holding Company. The text details the number of new shares, the purpose of the funds (acquisition of securities of other corporations), and the method of issuance. This falls under the category of capital structure changes and financing activities.
2023-06-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.